Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New sedative dose study aims for safer surgery in seniors

NCT ID NCT07333508

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at fospropofol disodium, a sedative, to find the best dose for elderly patients (65 and older) having leg surgery with spinal anesthesia. The goal is to keep patients comfortably asleep without over-sedating them. Sixty participants will receive different doses to determine the amount that works for 95% of people.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
fospropofol disodium
What this could lead to
If successful, this could help doctors use a safer, more precise dose of fospropofol for sedation in elderly patients during surgery.
What could go wrong
This is a small, early-phase trial with only 60 patients, so results may not apply to everyone. The drug may cause side effects like low blood pressure or breathing problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jan 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

65 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥65 years, no gender restriction * Scheduled for elective lower extremity surgery with spinal anesthesia * ASA physical status classification Ⅰ-Ⅲ * BMI 18.5-28.0 * Written informed consent obtained from patients or their guardians Exclusion Criteria: * Age \<65 years; * Non-lower extremity surgery or conversion to general anesthesia; * ASA physical status classification Ⅳ or above; * BMI \<18.5 or \>28.0; * History of drug abuse or alcohol dependence; * Preoperative use of sedative or analgesic drugs; * Refusal to participate or inability to sign informed consent; * Severe arrhythmia or myocardial infarction within 3 months; * Severe liver or kidney dysfunction; * Severe respiratory diseases; * Coagulopathy; * Uncorrected severe electrolyte disturbance; * History of mental illness or cognitive impairment.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Lower extremity surgery are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430030, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.